| Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients G Siravegna, B Mussolin, M Buscarino, G Corti, A Cassingena, ... Nature medicine 21 (7), 795-801, 2015 | 1171 | 2015 |
| Combination of hypoglycemia and metformin impairs tumor metabolic plasticity and growth by modulating the PP2A-GSK3β-MCL-1 axis M Elgendy, M Ciro, A Hosseini, J Weiszmann, L Mazzarella, E Ferrari, ... Cancer cell 35 (5), 798-815. e5, 2019 | 290 | 2019 |
| Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine M Donadelli, C Costanzo, S Beghelli, MT Scupoli, M Dandrea, A Bonora, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1773 (7), 1095-1106, 2007 | 191 | 2007 |
| cAMP-dependent protein kinase: role in normal and malignant growth YS Cho-Chung, S Pepe, T Clair, ADO Budillon, M Nesterova Critical reviews in oncology/hematology 21 (1-3), 33-61, 1995 | 190 | 1995 |
| Modulation of pancreatic cancer chemoresistance by inhibition of TAK1 D Melisi, Q Xia, G Paradiso, J Ling, T Moccia, C Carbone, A Budillon, ... Journal of the National Cancer Institute 103 (15), 1190-1204, 2011 | 185 | 2011 |
| Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ A Noto, C De Vitis, ME Pisanu, G Roscilli, G Ricci, A Catizone, ... Oncogene 36 (32), 4573-4584, 2017 | 184 | 2017 |
| Critical role of both p27KIP1and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, in … E Di Gennaro, M Barbarino, F Bruzzese, S De Lorenzo, M Caraglia, ... Journal of cellular physiology 195 (1), 139-150, 2003 | 184 | 2003 |
| New perspective for an old antidiabetic drug: metformin as anticancer agent A Leone, E Di Gennaro, F Bruzzese, A Avallone, A Budillon Advances in Nutrition and Cancer, 355-376, 2014 | 180 | 2014 |
| Electromagnetic fields at mobile phone frequency induce apoptosis and inactivation of the multi‐chaperone complex in human epidermoid cancer cells M Caraglia, M Marra, F Mancinelli, G D'ambrosio, R Massa, A Giordano, ... Journal of cellular physiology 204 (2), 539-548, 2005 | 174 | 2005 |
| HDAC inhibition potentiates immunotherapy in triple negative breast cancer M Terranova-Barberio, S Thomas, N Ali, N Pawlowska, J Park, G Krings, ... Oncotarget 8 (69), 114156, 2017 | 173 | 2017 |
| The Primary Occurrence of BRAFV600E Is a Rare Clonal Event in Papillary Thyroid Carcinoma A Guerra, MR Sapio, V Marotta, E Campanile, S Rossi, I Forno, ... The Journal of Clinical Endocrinology & Metabolism 97 (2), 517-524, 2012 | 172 | 2012 |
| Emerging anti-cancer molecular mechanisms of aminobisphosphonates M Caraglia, D Santini, M Marra, B Vincenzi, G Tonini, A Budillon Endocrine-related cancer 13 (1), 7-26, 2006 | 171 | 2006 |
| HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT F Bruzzese, A Leone, M Rocco, C Carbone, G Piro, M Caraglia, ... Journal of cellular physiology 226 (9), 2378-2390, 2011 | 163 | 2011 |
| Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15 F Bruzzese, C Hägglöf, A Leone, E Sjöberg, MS Roca, S Kiflemariam, ... Cancer research 74 (13), 3408-3417, 2014 | 145 | 2014 |
| A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome A Guerra, L Fugazzola, V Marotta, M Cirillo, S Rossi, V Cirello, I Forno, ... The Journal of Clinical Endocrinology & Metabolism 97 (7), 2333-2340, 2012 | 145 | 2012 |
| Expression of COX‐2, mPGE‐synthase1, MDR‐1 (P‐gp), and Bcl‐xL: a molecular pathway of H pylori‐related gastric carcinogenesis G Nardone, A Rocco, D Vaira, S Staibano, A Budillon, F Tatangelo, ... The Journal of pathology 202 (3), 305-312, 2004 | 142 | 2004 |
| Oxidative stress gene expression profile correlates with cancer patient poor prognosis: identification of crucial pathways might select novel therapeutic approaches A Leone, MS Roca, C Ciardiello, S Costantini, A Budillon Oxidative Medicine and Cellular Longevity 2017 (1), 2597581, 2017 | 133 | 2017 |
| The multidrug transporter P-glycoprotein: a mediator of melanoma invasion? M Colone, A Calcabrini, L Toccacieli, G Bozzuto, A Stringaro, M Gentile, ... Journal of Investigative Dermatology 128 (4), 957-971, 2008 | 133 | 2008 |
| NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer SS Faria, S Costantini, VCC de Lima, VP de Andrade, M Rialland, ... Journal of Biomedical Science 28, 1-15, 2021 | 130 | 2021 |
| Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients R Bei, A Budillon, L Masuelli, V Cereda, D Vitolo, E Di Gennaro, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004 | 130 | 2004 |
Michele CaragliaProfessore Ordinario di Biochimica, Università della Campania "L. Vanvitelli", Dipartimento diPreverjeni e-poštni naslov na unicampania.it
